ABSTRACT
Background The genetic component of early-onset Alzheimer’s disease (EOAD), accounting for ∼10% of all Alzheimer’s disease (AD) cases, is largely unexplained. Recent studies suggest that EOAD may be enriched for variants acting in the lipid pathway.
Objective To examine the shared genetic heritability between EOAD and the lipid pathway by genome-wide multi-trait genetic covariance analyses.
Methods Summary statistics were obtained from the GWAS meta-analyses of EOAD by the Alzheimer’s Disease Genetics Consortium (n=19,668) and five blood lipid traits by the Global Lipids Genetics Consortium (n=1,320,016), and genetic covariance analyses were performed via SUPERGNOVA. Genes in linkage disequilibrium (LD) with top EOAD hits in identified regions of covariance with lipid traits were scored and ranked for causality by combining evidence from gene-based analysis, AD-risk scores incorporating transcriptomic and proteomic evidence, eQTL data, eQTL colocalization analyses, DNA methylation data, and single-cell RNA sequencing analyses.
Results Local genetic covariance analyses identified 3 regions of covariance between EOAD and at least one lipid trait. Gene prioritization nominated 3 likely causative genes at these loci: ANKDD1B, CUZD1, and MS4A64.
Conclusion The current study identified genetic covariance between EOAD and lipids, providing further evidence of shared genetic architecture and mechanistic pathways between the two traits.
Competing Interest Statement
Carlos Cruchaga receives research support from: Biogen, EISAI, Alector and Parabon. The funders of the study had no role in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. Carlos Cruchaga is a member of the advisory board of Vivid genetics, Halia Therapeutics and ADx Healthcare.
Funding Statement
This study was supported by NIH grants R01AG064614 (CR, GB, CC), RF1AG054080 (CR, GB), P30AG066462 (CR), R01AG044546 (CC), P01AG003991(CC), RF1AG053303 (CC), RF1AG058501 (CC), U01AG058922 (CC)), U01AG032984 (GS, LSW), U54AG052427 (GS, LSW), the Alzheimer Association (NIRG-11-200110 (CC), BAND-14-338165 (CC), AARG-16-441560 (CC) and BFG-15-362540 (CC). ROSMAP is supported by P30AG10161, P30AG72975, R01AG15819, R01AG17917, U01AG46152, and U01AG61356. ROSMAP resources can be requested at https://www.radc.rush.edu and www.synpase.org.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The EOAD summary statistics will be publicly available upon publication of the relevant paper here: https://adsp.niagads.org/ The lipids summary statistics are available here: https://csg.sph.umich.edu/willer/public/glgc-lipids2021/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The EOAD summary statistics will be publicly available upon publication of the relevant paper here: https://adsp.niagads.org/ The lipids summary statistics are available here: https://csg.sph.umich.edu/willer/public/glgc-lipids2021/
